TPSF
CPRX

Texas Permanent School Fund’s Catalyst Pharmaceutical CPRX Stock Holding History

Texas Permanent School Fund’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-97,747
Closed -$1.56M – 320
2024
Q1 		$1.56M Buy
97,747
+11,176
+13% +$168K 0.01% 1165
2023
Q4 		$1.46M Buy
86,571
+1,483
+2% +$20.3K 0.01% 1173
2023
Q3 		$995K Sell
85,088
-7,331
-8% -$98.1K 0.01% 1250
2023
Q2 		$1.24M Buy
92,419
+10,122
+12% +$146K 0.01% 1182
2023
Q1 		$1.36M Buy
82,297
+21,497
+35% +$355K 0.01% 1130
2022
Q4 		$1.13M Sell
60,800
-7,233
-11% -$111K 0.02% 1060
2022
Q3 		$873K Buy
+68,033
New +$806K 0.01% 1156

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Texas Permanent School Fund's CPRX Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Catalyst Pharmaceutical (CPRX) in Q2 2024, closing a stake of 97,747 shares — an estimated $1.56M sold.

Texas Permanent School Fund first reported a position in CPRX in Q3 2022 and held it in 7 quarters. The position peaked at $1.56M in Q1 2024. 271 funds tracked by Wall St. Rank hold CPRX as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Catalyst Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 97,747 Catalyst Pharmaceutical shares in Q2 2024, an estimated $1.56M.
  • Texas Permanent School Fund first reported a position in Catalyst Pharmaceutical in Q3 2022 and held it in 7 quarters.
  • Texas Permanent School Fund's Catalyst Pharmaceutical position peaked at $1.56M in Q1 2024.
  • 271 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.